Research Topics
| Jean Winoc DecousserSummaryAffiliation: Centre Hospitalier de Versailles Country: France Publications
| Collaborators
|
Detail Information
Publications
First report of clinical and microbiological failure in the eradication of glycopeptide-intermediate methicillin-resistant Staphylococcus aureus carriage by mupirocinJ W Decousser
Department of Hospital Health, Centre Hospitalier de Versailles, 177 rue de Versailles, 78157, Le Chesnay Cedex, France
Eur J Clin Microbiol Infect Dis 22:318-9. 2003
Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 250 invasive Streptococcus pneumoniae isolates from FranceJ W Decousser
Department of Hospital Health, Centre Hospitalier de Versailles, 177 rue de Versailles, 78157 Le Chesnay Cedex, France
Eur J Clin Microbiol Infect Dis 22:561-5. 2003..e., 0.25 micro g/ml for both agents). Faropenem seems to be a promising antimicrobial agent for the treatment of adult and pediatric Streptococcus pneumoniae infections...
Multicentre study of the molecular epidemiology, serotypes and antimicrobial susceptibility patterns of invasive Streptococcus pneumoniae invasive isolated from children in the Ille de France areaJ W Decousser
Department of Hospital Health, Centre Hospitalier de Versailles, 177 rue de Versailles, 78157, Le Chesnay Cedex, France
Eur J Clin Microbiol Infect Dis 23:27-33. 2004..The use of the seven-valent conjugated vaccine is a critical measure to prevent invasive pneumococci infections in children in the Ille de France area...
Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002Jean Winoc Decousser
centre hospitalier de Versailles André Mignot, Service d Hygiène Hospitalière, 177 rue de Versailles, 78157 Le Chesnay Cedex, France
Antimicrob Agents Chemother 48:3636-9. 2004..The genetic homogeneity of some serogroups, including serogroup 1, enhanced the risk of epidemiological changes...
Nationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in FranceMuriel Galas
Service d Hygiène Hospitalière, Centre Hospitalier de Versailles, Le Chesnay, France
Antimicrob Agents Chemother 52:786-9. 2008..5%), Enterobacter aerogenes (23.7%), and Klebsiella pneumoniae (14.8%). Molecular analysis underlined the polyclonal spread of CTX-M-expressing E. coli, primarily isolates of the CTX-M-1 subgroup...
In vitro activity of ertapenem against bacteraemic pneumococci: report of a French multicentre study including 339 strainsJean-Winoc Decousser
J Antimicrob Chemother 55:396-8. 2005
Insertion sequence ISEcp1B is involved in expression and mobilization of a bla(CTX-M) beta-lactamase geneLaurent Poirel
Service de Bacteriologie Virologie, Hopital de Bicetre, Assistance Publique Hopitaux de Paris, Faculte de Medecine Paris Sud, 94275 Le Kremlin Bicetre cedex, France
Antimicrob Agents Chemother 47:2938-45. 2003..The ability of ISEcp1-like elements to mobilize and to promote the expression of beta-lactamase genes may explain, in part, the current spread of CTX-M-type enzymes worldwide...
New real-time PCR assay using locked nucleic acid probes to assess prevalence of ParC mutations in fluoroquinolone-susceptible Streptococcus pneumoniae isolates from FranceJean Winoc Decousser
Laboratoire de Biologie, Centre Hospitalier de Dourdan, 2 Rue du Potelet, 91415 Dourdan, France
Antimicrob Agents Chemother 50:1594-8. 2006..Only silent mutations were detected among 236 French invasive fluoroquinolone-susceptible strains. This test could be useful for some high-risk patients or in national surveys...
Fatal relapse of a purulent pleurisy caused by Campylobacter fetus subsp. fetusJean Winoc Decousser
Department of Biology, Centre Hospitalier de Dourdan, 91415 Dourdan, France
J Clin Microbiol 45:2334-6. 2007..Bacteremia has been well described, but pleurisy remains very uncommon. We report the recurrent isolation of a C. fetus subsp. fetus strain during two episodes of pleural effusion with a fatal outcome...
Dalbavancin, a long-acting lipoglycopeptide for the treatment of multidrug-resistant Gram-positive bacteriaJean Winoc Decousser
Department of Biology, Centre Hospitalier de Dourdan, Dourdan, France
Expert Rev Anti Infect Ther 5:557-71. 2007..Other preliminary in vitro and in vivo data have identified putative interest of dalbavancin in endocarditis, osteitis, diabetic foot, respiratory tract or joint infection...
ISEcp1B-mediated transposition of blaCTX-M in Escherichia coliLaurent Poirel
, , , , France
Antimicrob Agents Chemother 49:447-50. 2005..We found that ISEcp1B was able to mobilize the adjacent bla(CTX-M-19) gene by a transpositional mechanism in Escherichia coli by recognizing a variety of DNA sequences as right inverted repeats...
